Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ABBV-141 by AbbVie for Fibrosis: Likelihood of Approval
ABBV-141 is under clinical development by AbbVie and currently in Phase I for Fibrosis. According to GlobalData, Phase I drugs...